1. Signaling Pathways
  2. GPCR/G Protein
  3. CXCR
  4. CXCR6 Isoform



CXCR6 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-122197
    Antagonist 99.88%
    ML339 is a selective CXCR6 antagonist with an IC50 of 140 nM. ML339 antagonizes β-arrestin recruitment and cAMP signaling pathway of human CXCR6 receptor induced by CXCL16, with IC50 of 0.3 μM and 1.4 μM, respectively. ML339 has no inhibitory effect on CXCR5CXCR4CXCR6 and apelin receptor (APJ), with IC50 >79 μM. ML339 has the potential to promote the development of prostate cancer research.